Gilead Sciences, Inc. (GILD)
152.70
+2.14
(+1.42%)
USD |
NASDAQ |
Sep 22, 16:00
152.93
+0.23
(+0.15%)
After-Hours: 20:00
Gilead Sciences Market Cap : 189.50B for Sept. 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 21, 2026 | 186.84B |
| September 18, 2026 | 186.29B |
| September 17, 2026 | 187.25B |
| September 16, 2026 | 183.27B |
| September 15, 2026 | 181.56B |
| September 14, 2026 | 181.69B |
| September 11, 2026 | 178.36B |
| September 10, 2026 | 179.71B |
| September 09, 2026 | 180.75B |
| September 08, 2026 | 181.98B |
| September 04, 2026 | 187.38B |
| September 03, 2026 | 187.66B |
| September 02, 2026 | 185.67B |
| September 01, 2026 | 186.05B |
| August 31, 2026 | 181.61B |
| August 28, 2026 | 180.79B |
| August 27, 2026 | 184.74B |
| August 26, 2026 | 183.78B |
| August 25, 2026 | 184.62B |
| August 24, 2026 | 182.10B |
| August 21, 2026 | 181.33B |
| August 20, 2026 | 178.01B |
| August 19, 2026 | 183.17B |
| August 18, 2026 | 178.01B |
| August 17, 2026 | 172.40B |
| Date | Value |
|---|---|
| August 14, 2026 | 171.70B |
| August 13, 2026 | 171.43B |
| August 12, 2026 | 168.61B |
| August 11, 2026 | 168.49B |
| August 10, 2026 | 165.13B |
| August 07, 2026 | 165.31B |
| August 06, 2026 | 162.40B |
| August 05, 2026 | 163.51B |
| August 04, 2026 | 167.85B |
| August 03, 2026 | 162.76B |
| July 31, 2026 | 161.59B |
| July 30, 2026 | 162.92B |
| July 29, 2026 | 164.72B |
| July 28, 2026 | 166.69B |
| July 27, 2026 | 161.98B |
| July 24, 2026 | 160.47B |
| July 23, 2026 | 162.40B |
| July 22, 2026 | 161.75B |
| July 21, 2026 | 161.68B |
| July 20, 2026 | 165.31B |
| July 17, 2026 | 166.64B |
| July 16, 2026 | 169.15B |
| July 15, 2026 | 163.44B |
| July 14, 2026 | 161.38B |
| July 13, 2026 | 163.07B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 130.49B |
| AbbVie, Inc. | 468.80B |
| Regeneron Pharmaceuticals, Inc. | 83.13B |
| Biogen, Inc. | 33.31B |
| Amgen, Inc. | 221.75B |
Market Cap Related Metrics
| PS Ratio | 6.254 |
| Price to Book Value | 16.02 |
| Price to Free Cash Flow | 14.76 |
| Price | 152.70 |
| Earnings Yield | -1.74% |
| Operating PE Ratio | 16.02 |
| Normalized PE Ratio | 32.14 |